Myriad Genetics
MYGN
#7319
Rank
C$0.75 B
Marketcap
C$7.83
Share price
-1.44%
Change (1 day)
-24.76%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -C$0.53 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are C$0.82 Billion. In 2025 the company made an earning of -C$0.56 Billion a decrease over its 2024 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.53 Billion-4.48%
2025 -C$0.56 Billion218.91%
2024 -C$0.18 Billion-53.49%
2023 -C$0.38 Billion88.72%
2022 -C$0.2 Billion172.08%
2021 -C$72.42 Million
2019 -C$37.72 Million-175.14%
2018 C$50.19 M-70.81%
2017 C$0.17 B22.22%
2016 C$0.14 B-38.8%
2015 C$0.22 B-6.12%
2014 C$0.24 B-41.07%
2013 C$0.41 B46.67%
2012 C$0.28 B15.84%
2011 C$0.24 B17.6%
2010 C$0.20 B-15.96%
2009 C$0.24 B
2007 -C$59.77 Million40.96%
2006 -C$42.4 Million
2003 -C$49.24 Million34.8%
2002 -C$36.53 Million89.21%
2001 -C$19.31 Million3.93%
2000 -C$18.58 Million21.76%
1999 -C$15.26 Million-25.61%
1998 -C$20.51 Million38.83%
1997 -C$14.78 Million-24.26%
1996 -C$19.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
C$10.35 B-1,969.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-C$0.27 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$62.61 M-111.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$50.15 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$1.89 B-442.02%๐Ÿ‡บ๐Ÿ‡ธ USA